1.0Reproductive Health Access Projecthttps://www.reproductiveaccess.orgReproductive Health Access Projecthttps://www.reproductiveaccess.org/author/reproductive-health-access-project/Update: FDA’s Decision on Mifepristone REMS - Reproductive Health Access Projectrich600338<blockquote class="wp-embedded-content" data-secret="kOOqDvMFkJ"><a href="https://www.reproductiveaccess.org/2022/02/update-fdas-decision-on-mifepristone-rems/">Update: FDA’s Decision on Mifepristone REMS</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.reproductiveaccess.org/2022/02/update-fdas-decision-on-mifepristone-rems/embed/#?secret=kOOqDvMFkJ" width="600" height="338" title="“Update: FDA’s Decision on Mifepristone REMS” — Reproductive Health Access Project" data-secret="kOOqDvMFkJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.reproductiveaccess.org/wp-content/uploads/2022/01/Abortion3.png10811081The US Food and Drug Administration (FDA) has long regulated mifepristone, also known as the abortion pill, under a Risk Evaluation and Mitigation Strategy (REMS). Despite mifepristone and misoprostol being one safe, effective way to provide abortion and early pregnancy loss (EPL) care, the FDA restrictions have limited where and who can provide this essential…